Welcome to Stanford Vascular & Endovascular Surgery
Welcome to Stanford Vascular and Endovascular Surgery. We are dedicated to the highest levels of patient care, professional education, and clinical and translational research.
The Division works continually to improve quality of life for patients with vascular diseases. We are privileged to work with an outstanding team of faculty and community vascular specialists, cardiologists and cardiac surgeons, radiologists, podiatrists, rehabilitation specialists, basic scientists, engineers and computer scientists. Our ongoing collaborations have promoted remarkable academic and clinical productivity involving new and dramatically improved techniques for the diagnosis and treatment of vascular disease, gaining the Division international recognition as a Vascular Center of Excellence.
The faculty is distinguished by expertise in many aspects of vascular disease management, but perhaps none more so than aortic aneurysm disease. Stanford Vascular Surgeons are recognized around the world as leaders in aortic aneurysm treatment and research.
Jason T. Lee, MD
Division Chief of Vascular Surgery
The Latest News
Department of Cardiothoracic SurgeryStanford Continues to Advance Ascending Aorta Treatments Through National ARISE III Clinical Trial
Learn how we are healing patients through science & compassion
Stanford Cardiovascular InstituteWhen Blood Vessels Trigger Heart Failure: A New Mechanism Driving Inherited Cardiomyopathy
Learn how we are healing patients through science & compassion
SurgeryOptimizing Surgical Care Through Clinical Trials with Dr. Shipra Arya
On the latest episode of Scrubcast, Dr. Shipra Arya discusses her groundbreaking PAUSE trial focused on optimizing care for frail patients. She also introduces her new WARRIORS trial, which aims to address sex-specific screening guidelines for abdominal aortic aneurysms in women.
SurgeryDepartment Announces Second Vice Chair Cohort
Stanford Surgery announced its second class of Associate Vice Chairs (AVC), effective September 1st.
Vascular & Endovascular SurgeryResident Dr. Keyuree Satam Selected for NHLBI-Funded Vascular Disease T32 Training Program
The Stanford Division of Vascular Surgery is pleased to announce that Dr. Keyuree Satam has been selected for the highly competitive Mechanisms and Innovation in Vascular Disease T32 Training Program.
Vascular & Endovascular SurgeryDr. Amanda Filiberto Receives VA Palo Alto Early Career Development Award to Advance Surgical Decision-Making Research
Stanford Vascular Surgery faculty member Dr. Amanda Filiberto has received a Veterans Affairs (VA) Palo Alto Early Career Development Award to support research focused on improving postoperative care for Veterans undergoing inpatient surgery.
Client ChallengeWhat is aortic dissection? Stanford doctor explains ‘scary’ condition linked to Lindsey Graham's death
Stanford's Dr. Jason Lee explains 'scary' condition linked to Lindsey Graham's death.
Heart BrokenHeart Broken
Scientist Nazish Sayed beat cancer only to face a new threat—from the very drugs that saved his life.
Vascular & Endovascular SurgeryVascular Surgery Graduates Two Residents and Vascular Medicine Fellow
Drs. Shaunak Adkar and Shernaz Dossabhoy graduate vascular surgery residency program. Dr. Sheena Amin graduates Vascular Medicine Fellowship.
stanfordvascular on InstagramVascular Annual Meeting 2026
Faculty, fellows, and trainees from Stanford Vascular Surgery participated in the 2026 Vascular Annual Meeting in Boston, sharing research and clinical insights with colleagues from across the specialty.
Connect With Us
LIMIT Clinical Trial
Led by Ronald Dalman, MD, the LIMIT Clinical Trial is studying whether metformin can slow the growth of abdominal aortic aneurysms in people without diabetes.